Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.

Mohamed Nabil ElshafeiAhmed El-BardissyAhmed KhalilMohammed DanjumaMahmood MubasherIbrahim Y AbubekerMouhand Faisal Hamad Mohamed

Published in: European journal of clinical investigation (2021)

This meta-analysis suggests a mortality benefit with colchicine when used in the treatment of COVID-19 patients. The majority of included studies were observational; thus, the findings of this review need to be further supported by the results of ongoing trials.

Keyphrases

systematic review
sars cov
cardiovascular events
case control
risk factors
meta analyses
randomized controlled trial
cross sectional
replacement therapy
smoking cessation